ReShape Lifesciences Inc. Files 8-K: Material Agreement
Ticker: HIND · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-filing
TL;DR
ReShape Lifesciences signed a big deal on Feb 15, 2025. 8-K filed.
AI Summary
On February 15, 2025, ReShape Lifesciences Inc. entered into a material definitive agreement. The filing also includes Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Obalon Therapeutics Inc., is incorporated in Delaware and headquartered in San Clemente, California.
Why It Matters
This 8-K filing indicates a significant new agreement for ReShape Lifesciences, which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Registrant
- February 15, 2025 (date) — Date of earliest event reported
- Obalon Therapeutics Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- San Clemente, California (location) — Principal executive offices location
FAQ
What type of material definitive agreement did ReShape Lifesciences Inc. enter into?
The filing states that ReShape Lifesciences Inc. entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 15, 2025.
What was ReShape Lifesciences Inc. formerly known as?
ReShape Lifesciences Inc. was formerly known as Obalon Therapeutics Inc.
In which state is ReShape Lifesciences Inc. incorporated?
ReShape Lifesciences Inc. is incorporated in Delaware.
What is the address of ReShape Lifesciences Inc.'s principal executive offices?
The address of ReShape Lifesciences Inc.'s principal executive offices is 18 Technology Drive, Suite 110, Irvine, CA 92618.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding ReShape Lifesciences Inc. (HIND).